Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
314.5 USD | +12.98% | +16.24% | +8.96% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.96% | 149B | |
+26.54% | 681B | |
+21.85% | 556B | |
-5.14% | 361B | |
+17.09% | 325B | |
+5.14% | 285B | |
+13.68% | 235B | |
+3.65% | 199B | |
-11.12% | 189B | |
-4.38% | 157B |
- Stock Market
- Equities
- AMGN Stock
- News Amgen Inc.
- Amgen Plans for Phase 3 Trial of Tezepelumab for Lung Disease